RU2165921C2 - Нитросоединения и фармацевтическая композиция, обладающие противовоспалительной и антитромботической активностями - Google Patents

Нитросоединения и фармацевтическая композиция, обладающие противовоспалительной и антитромботической активностями Download PDF

Info

Publication number
RU2165921C2
RU2165921C2 RU98110565/04A RU98110565A RU2165921C2 RU 2165921 C2 RU2165921 C2 RU 2165921C2 RU 98110565/04 A RU98110565/04 A RU 98110565/04A RU 98110565 A RU98110565 A RU 98110565A RU 2165921 C2 RU2165921 C2 RU 2165921C2
Authority
RU
Russia
Prior art keywords
ono
inflammatory
products
cox
group
Prior art date
Application number
RU98110565/04A
Other languages
English (en)
Russian (ru)
Other versions
RU98110565A (ru
Inventor
Солдато Пьеро Дел
Франческо Санниколо
Original Assignee
Никокс С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Никокс С.А. filed Critical Никокс С.А.
Publication of RU98110565A publication Critical patent/RU98110565A/ru
Application granted granted Critical
Publication of RU2165921C2 publication Critical patent/RU2165921C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00—Esters of nitric or nitrous acid
    • C07C203/02—Esters of nitric acid
    • C07C203/04—Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU98110565/04A 1995-10-31 1996-10-29 Нитросоединения и фармацевтическая композиция, обладающие противовоспалительной и антитромботической активностями RU2165921C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI002263A IT1276071B1 (it) 1995-10-31 1995-10-31 Compositi ad attivita' anti-infiammatoria
ITM195A002263 1995-10-31

Publications (2)

Publication Number Publication Date
RU98110565A RU98110565A (ru) 2000-04-27
RU2165921C2 true RU2165921C2 (ru) 2001-04-27

Family

ID=11372460

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98110565/04A RU2165921C2 (ru) 1995-10-31 1996-10-29 Нитросоединения и фармацевтическая композиция, обладающие противовоспалительной и антитромботической активностями

Country Status (18)

Country Link
US (1) US6040341A (enExample)
EP (1) EP0871606B1 (enExample)
JP (1) JP3880067B2 (enExample)
KR (1) KR100546038B1 (enExample)
AT (1) ATE193883T1 (enExample)
AU (1) AU709338B2 (enExample)
BR (1) BR9611175B1 (enExample)
CA (1) CA2235996C (enExample)
DE (1) DE69608916T2 (enExample)
DK (1) DK0871606T3 (enExample)
ES (1) ES2148808T3 (enExample)
GR (1) GR3033827T3 (enExample)
HU (1) HUP9802986A3 (enExample)
IT (1) IT1276071B1 (enExample)
PT (1) PT871606E (enExample)
RU (1) RU2165921C2 (enExample)
SI (1) SI0871606T1 (enExample)
WO (1) WO1997016405A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2322434C2 (ru) * 2002-09-20 2008-04-20 Никокс С.А. Способ получения no-донорных соединений, таких как no-донорный диклофенак

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043232A (en) * 1997-07-23 2000-03-28 Nitromed, Inc. Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
IT1276071B1 (it) * 1995-10-31 1997-10-24 Nicox Ltd Compositi ad attivita' anti-infiammatoria
US20050137191A1 (en) * 1996-06-04 2005-06-23 Thatcher Gregory R. Nitrate esters and their use for mitigating cellular damage
US7115661B1 (en) 1999-12-29 2006-10-03 Queen's University At Kingston Methods and compositions for mitigating pain
US20040082652A1 (en) * 1996-09-04 2004-04-29 Nicox S.A. Nitric ester derivatives and their use in treating gastrointestinal tumors
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
US6136804A (en) 1998-03-13 2000-10-24 Merck & Co., Inc. Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
WO1999045913A1 (en) * 1998-03-13 1999-09-16 Merck & Co., Inc. Combination therapy and composition for acute coronary ischemic syndrome and related conditions
ES2136581B1 (es) * 1998-05-27 2000-09-16 Uriach & Cia Sa J Uso de derivados del acido-2-hidroxi-4-trifluorometilbenzoico para la preparacion de medicamentos utiles para inhibir el factor de transcripcion nuclear nf-kb.
AU4428899A (en) 1998-06-08 1999-12-30 Advanced Medicine, Inc. Multibinding inhibitors of cyclooxygenase-2
EP1117398A2 (en) * 1998-09-28 2001-07-25 Merck & Co., Inc. A method for treating inflammatory diseases by administering a thrombin inhibitor
US6297260B1 (en) 1998-10-30 2001-10-02 Nitromed, Inc. Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
IT1307928B1 (it) * 1999-01-26 2001-11-29 Nicox Sa Metodo di sintesi di nitrossimetilfenil esteri di derivatidell'aspirina.
IT1308633B1 (it) * 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
IT1311924B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
US6509377B1 (en) * 1999-05-26 2003-01-21 J. Uriach & Cia, S.A. Use of a 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-κB
IT1312115B1 (it) 1999-06-24 2002-04-04 Nicox Sa Composti amorfi e relative composizioni farmaceutiche
ITMI991517A1 (it) 1999-07-09 2001-01-09 Nicox Sa Procedimento per ottenere nitrossimetil fenil esterni di derivati dell'acido salicilico
IT1313596B1 (it) * 1999-08-04 2002-09-09 Nicox Sa Processo per la preparazione di nitrossialchil esteri del naproxene
JP2003523958A (ja) * 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−２の阻害剤、組成物ならびに使用法
US6538033B2 (en) * 2000-08-29 2003-03-25 Huntington Medical Research Institutes Nitric oxide donor compounds
IT1319202B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
ATE338544T1 (de) 2000-12-21 2006-09-15 Nitromed Inc Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US6696592B2 (en) 2001-05-22 2004-02-24 Nicox-S.A. Methods of making 21-[4′-(nitrooxyalkyl)benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof
ITMI20011240A1 (it) * 2001-06-13 2002-12-13 Nicox Sa Farmaci per le vasculopatie
ITMI20011308A1 (it) 2001-06-21 2002-12-21 Nicox Sa Farmaci per il dolore cronico
ITMI20011307A1 (it) * 2001-06-21 2002-12-21 Nicox Sa Farmaci per l'epilessia
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
BR0307420A (pt) * 2002-02-04 2004-12-21 Werner Haas Compostos, composições farmacêuticas e métodos para impedir e/ou tratar doença em mamìfero
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
WO2003094924A1 (en) * 2002-05-10 2003-11-20 Merck & Co., Inc. Combination therapy for treating cyclooxygenase-2 mediated diseases in patients at risk of thrombotic cardiovascular events
US20050215611A1 (en) * 2002-05-10 2005-09-29 Hunt Richard H Combination therapy for treating cyclooxygenase-2 mediated diseases in patients at risk of thrombotic cardiovascular events
EP1539134A4 (en) 2002-06-11 2007-04-11 Nitromed Inc SELECTIVE INHIBITORS OF CYCLOOXIGENASE-2 NITROSIS AND / OR NITROSYLES, COMPOSITIONS AND METHODS OF USE
AU2003247622A1 (en) * 2002-06-27 2004-01-19 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
US7211598B2 (en) * 2002-06-28 2007-05-01 Nitromed, Inc. Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
AU2003247792B2 (en) 2002-07-03 2009-09-24 Nicox S.A. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
EP1527045A1 (en) 2002-07-26 2005-05-04 Merck Frosst Canada & Co. Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
CA2493156A1 (en) 2002-07-29 2004-02-05 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
ITMI20021861A1 (it) * 2002-08-29 2004-02-29 Nicox Sa Procedimento di sintesi di nitrossialchilesteri di acidi carbossilici, intermedi impiegabili in detto procedimento e loro preparazione.
WO2004037843A2 (en) * 2002-10-25 2004-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
ITMI20022658A1 (it) * 2002-12-17 2004-06-18 Nicox Sa Farmaci per il dolore cronico.
US7166638B2 (en) 2003-05-27 2007-01-23 Nicox S.A. Statin derivatives
US7169805B2 (en) 2003-05-28 2007-01-30 Nicox S.A. Captopril derivatives
CA2529478A1 (en) 2003-06-19 2004-12-23 Nicox S.A. Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases
US7585997B2 (en) * 2003-12-31 2009-09-08 Chesterford Enterprises Limited Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
EP1789091B1 (en) 2004-08-26 2010-08-25 Piramal Life Sciences Limited Prodrugs containing novel bio-cleavable linkers
US7521435B2 (en) * 2005-02-18 2009-04-21 Pharma Diagnostics, N.V. Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
ATE485261T1 (de) 2005-11-23 2010-11-15 Nicox Sa Salicylsäurederivate
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
JP2007275193A (ja) * 2006-04-04 2007-10-25 Fujifilm Corp 光プローブおよび光断層画像化装置
CA2705463C (en) * 2007-08-10 2014-10-07 Basil Rigas Anti-inflammatory compounds and uses thereof
WO2010118968A1 (en) 2009-04-16 2010-10-21 Nicox S.A. No-donor aspirin derivatives
WO2011160974A2 (en) 2010-06-21 2011-12-29 Nicox S.A. Statin derivatives
WO2012145520A2 (en) 2011-04-19 2012-10-26 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
ES2628634T3 (es) 2011-07-21 2017-08-03 Alfama, Inc. Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
US9844599B2 (en) 2013-01-21 2017-12-19 Apparao Satyam Nitric oxide releasing produgs of therapeutic agents
US20140271923A1 (en) 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
CN117843491A (zh) * 2023-12-29 2024-04-09 陕西中医药大学 4-(2-(硝基氧基)乙基)-1,2-亚苯基二乙酸酯及其合成方法、应用和药物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001668A1 (en) * 1990-07-26 1992-02-06 Italfarmaco S.P.A. Benzoic acid substituted derivatives having cardiovascular activity
WO1994012463A1 (en) * 1992-11-26 1994-06-09 Nicox Limited Nitric esters having a pharmacological activity and process for their preparation
WO1995030641A1 (en) * 1994-05-10 1995-11-16 Nicox S.A. Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU218923B (hu) * 1993-10-06 2000-12-28 Nicox S.A. Gyulladásgátló és/vagy fájdalomcsillapító hatású nitrát-észterek, ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
IT1276071B1 (it) * 1995-10-31 1997-10-24 Nicox Ltd Compositi ad attivita' anti-infiammatoria

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001668A1 (en) * 1990-07-26 1992-02-06 Italfarmaco S.P.A. Benzoic acid substituted derivatives having cardiovascular activity
WO1994012463A1 (en) * 1992-11-26 1994-06-09 Nicox Limited Nitric esters having a pharmacological activity and process for their preparation
WO1995030641A1 (en) * 1994-05-10 1995-11-16 Nicox S.A. Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2322434C2 (ru) * 2002-09-20 2008-04-20 Никокс С.А. Способ получения no-донорных соединений, таких как no-донорный диклофенак

Also Published As

Publication number Publication date
EP0871606B1 (en) 2000-06-14
SI0871606T1 (en) 2000-08-31
BR9611175A (pt) 1999-03-30
ITMI952263A1 (it) 1997-05-01
DK0871606T3 (da) 2000-07-31
HUP9802986A2 (hu) 1999-04-28
CA2235996A1 (en) 1997-05-09
CA2235996C (en) 2007-01-02
HUP9802986A3 (en) 1999-12-28
JP3880067B2 (ja) 2007-02-14
KR19990067247A (ko) 1999-08-16
US6040341A (en) 2000-03-21
EP0871606A1 (en) 1998-10-21
WO1997016405A1 (en) 1997-05-09
ITMI952263A0 (enExample) 1995-10-31
DE69608916D1 (de) 2000-07-20
GR3033827T3 (en) 2000-10-31
AU709338B2 (en) 1999-08-26
ATE193883T1 (de) 2000-06-15
IT1276071B1 (it) 1997-10-24
AU7495096A (en) 1997-05-22
JPH11514636A (ja) 1999-12-14
DE69608916T2 (de) 2001-01-11
BR9611175B1 (pt) 2009-01-13
KR100546038B1 (ko) 2006-10-04
ES2148808T3 (es) 2000-10-16
PT871606E (pt) 2000-11-30

Similar Documents

Publication Publication Date Title
RU2165921C2 (ru) Нитросоединения и фармацевтическая композиция, обладающие противовоспалительной и антитромботической активностями
JP4043046B2 (ja) 消炎、鎮痛および抗血栓活性を有するニトロ化合物およびそれらの組成物
CA2173582C (en) Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
CA2150229C (en) Nitric esters having a pharmacological activity and process for their preparation
EP2057139B1 (en) Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
PT1215201E (pt) Processo para a preparação de ariloctanoil amidas
JP2000511175A (ja) ビフェニルスルホンアミドマトリックスメタロプロテイナーゼ阻害剤
MC1231A1 (fr) Nouveaux benzamides heterocycliques substitues,leurs procedes de preparation et leur application comme modificateurs du comportement
US3553258A (en) Phenylalanine compounds
WO2005033059A1 (es) Compuestos útiles para el tratamiento de enfermedades asociadas a la formación de fibrilas amiloides
IL128020A (en) Alpha-amino acid amides, preparation thereof and pharmaceutical compositions containing them
PL171844B1 (pl) P ochodne 2-amino-1,2,3,4-tetrahydronaftalenu PL PL PL
FR2532647A1 (fr) Thioesters d'acide acetylsalicylique, procede pour les preparer et compositions pharmaceutiques qui en renferment
Paliwal et al. Synthesis and biological evaluation of mutual prodrugs of carboxylic group containing some non-steroidal anti-inflammatory drugs and propyphenazone
JPS6039069B2 (ja) アミン誘導体
JPH05500214A (ja) ターシヤリーアルキルエステル類の新規な合成方法
AU661906B2 (en) 5-amino-2-phenoxysulfonanilide compound
GB2134111A (en) Pyrrole-2-acetylamino acid derivatives
NZ262219A (en) 3-hydroxyanthranilic acid derivatives, preparation, intermediates and pharmaceutical compositions thereof
WO1988009785A1 (en) Butenoic acid amides, their salts, pharmaceutical compositions containing them and process for preparing same
FR2552427A1 (fr) Nouveau procede de preparation de l'hydroxy-2 (hydroxy-1((methyl-1 phenyl-3 propyl) amino)-2 ethyl)-5 benzamide et compositions therapeutiques a base du compose obtenu selon ce nouveau procede
WO2007110876A2 (en) Novel sulfonanilide derivatives, pharmaceutical compositions comprising the same and process thereof
CA2155666C (en) Novel derivatives of 3-hydroxy anthranilic acid, methods and intermediates for their preparation, novel pharmaceutical compositions and the use thereof
MC513A1 (fr) Nouveaux dérivés de la semicarbazide et leur preparation
JPH01199940A (ja) フェノキシ酢酸誘導体

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20091030